Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival.
about
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.
P2860
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Neuroblastoma patients with hi ...... improved event-free survival.
@en
type
label
Neuroblastoma patients with hi ...... improved event-free survival.
@en
prefLabel
Neuroblastoma patients with hi ...... improved event-free survival.
@en
P2093
P2860
P1433
P1476
Neuroblastoma patients with hi ...... improved event-free survival.
@en
P2093
Christian Jensen
Ina Müller
Karoline Ehlert
Madlen Jüttner
Maxi Zumpe
Nikolai Siebert
Silke Kietz
P2860
P304
P356
10.1080/2162402X.2016.1235108
P577
2016-09-26T00:00:00Z